This content was created by Everyday Health Media on behalf of an advertiser.
More Information.
Content on this page was created by the Everyday Health Media team and is funded by an advertiser. The content conforms to Everyday Health Media’s editorial standards for accuracy, objectivity, and balance. The advertiser may select the specialty area but does not edit or approve the content.
Chronic Myeloid Leukemia in Adults
In CML, The Importance of Monitoring Cardiovascular Health
Catherine Lai, MD, MPH, of the University of Pennsylvania, discusses the role of regular cardiovascular check-ups in patients taking TKIs. (2:12)
In Patients with CML, Frailty—Not Age—Is a Strong Predictor of Poor Outcomes
Investigators examined the impact of frailty on hospital outcomes in patients with chronic myeloid leukemia, finding frail patients to be at 4 times the risk of in-hospital mortality.
Secondary Hematologic Malignancies on the Rise Following CLL
Utilizing data from SEER, a team of U.S.-based researchers set out to determine the real-world burden of secondary hematologic malignancies in patients with chronic lymphocytic leukemia.
In CML Patients, What Happens When Low-dose TKIs are Discontinued?
TKI dose reduction can be done in CML patients as a way to mitigate adverse events. These investigators went further, conducting a retrospective study to assess the outcome when CML patients discontinued low-dose TKIs.
CML Patients Treated with TKIs have Lower COVID-19 Fatality Rates
Investigators found that patients with CML treated with TKIs had a lower fatality rate when compared with reports in the literature, suggesting future studies of TKIs as a potential COVID-19 treatment are warranted.
Chronic Hematological Malignancies: The Caregivers Face Challenges, Too
Patients with chronic hematological malignancies bear significant physical and emotional pain—and so do their caregivers. Sometimes the strain faced by caregivers impedes the provision of quality care.